| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 15 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 2 | TACROLIMUS OINTMENT 0.1% | 14 |
| 3 | MYCOPHENILIC ACID | 10 |
| 4 | MYCOPHENOLIC ACID | 10 |
| 5 | INFLIXIMAB | 4 |
| 6 | MYCOPHENOLATE MOFETIL | 4 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 4 |
| 8 | FLUCYTOSINE | 3 |
| 9 | POSACONAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 3 | 0.0021 |
| 1 | MYCOPHENILIC ACID | 10 | 0.0005 |
| 2 | MYCOPHENOLIC ACID | 10 | 0.0003 |
| 3 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 4 | POSACONAZOLE | 3 | 0.0002 |
| 5 | AMPHOTERICIN B | 2 | 0.0002 |
| 6 | ATOVAQUONE | 1 | 0.0001 |
| 7 | TACROLIMUS OINTMENT 0.1% | 14 | 0.0001 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 | 0.0001 |
| 9 | TACROLIMUS | 15 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 3 | Polyene Antifungal [EPC] | 4 | 0.0001 |
| 4 | Antimalarial [EPC] | 1 | 0.0001 |
| 5 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 6 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |